Runx2 determines bone maturity and turnover rate in postnatal bone development and is involved in bone loss in estrogen deficiency
Zenjiro Maruyama(The University of Osaka), Toshihisa Komori(Nagasaki University), Ryo Fukuyama(Setsunan University), Takashi Fujita(Gifu Prefectural Tajimi Hospital), Hiroshi Kawaguchi(Tokyo Medical Center), Tatsuya Furuichi(Iwate University), Norio Amizuka(Hokkaido University), Naoko Kanatani(The University of Osaka), Takeshi Moriishi(University of Nagasaki), Kouhei Nakamura(University of Tokyo Hospital), Wenguang Liu(Tianjin University), Kozo Nakamura(Towa Pharmaceutical (Japan)), Masako Ito(Nagasaki University), Carolina A. Yoshida(The University of Osaka), Kei Yamana(NOF Corporation (Japan)), Toshihiro Miyazaki(Nagasaki University), Hideki Kitaura(Tohoku University)
Cited by 233
Related Papers
Prevalence of knee osteoarthritis, lumbar spondylosis, and osteoporosis in Japanese men and women: the research on osteoarthritis/osteoporosis against disability study
|Journal of Bone and Mineral Metabolism|2009|820
Regulation of Proliferation, Differentiation and Functions of Osteoblasts by Runx2
|International Journal of Molecular Sciences|2019|812
Regulation of bone development and extracellular matrix protein genes by RUNX2
|Cell and Tissue Research|2009|799
Regulation of Osteoblast Differentiation Mediated by Bone Morphogenetic Proteins, Hedgehogs, and Cbfa1
|Endocrine Reviews|2000|665